I was using 4-AP a few years ago, and found it to be brilliant. However, this trial really seems like a "check the boxes" so they can say they went through the trial process. I would not be surprised if they had better results with caffeine or even better with a prescription Amphetamine. But do not get me wrong, I am glad it is now available, and even though it costs an arm and a leg, I would be interested to compare it to compounded 4-AP.Acorda Therapeutics, Inc wrote:... Ampyra® (dalfampridine) Extended Release Tablets, 10 mg demonstrated clinically relevant improvements in walking ability as measured by patient self-report on the 12-Item Multiple Sclerosis Walking Scale (MSWS-12), regardless of either their baseline Expanded Disability Status Scale (EDSS) score or baseline walking speed.
Users browsing this forum: No registered users